More than 25 Early- to Late-Stage Med Device Companies Seeking Funding and/or Strategic Partnership Confirmed to Date to Present at Medtech Insight and Windhover Information's ''In3 Europe'' Investment and Partnering Conference
April 29-30, 2008, Paris, France, The Hilton Paris
NEWPORT BEACH, Calif.--(Business Wire)--
Medtech Insight, a division of Windhover Information, Inc. and a
leading provider of business information for the medical device
industry, has announced that 26 early- to late-stage medical device
companies from around the world are confirmed to date to present at
its "Investment In Innovation (In3) Europe" conference, being held
April 29-30, 2008 at The Hilton Paris in Paris, France. In3 Europe -
the company's 30th In3 conference - will showcase a total of over 30
highly promising start-up med device companies from around the world
presenting to an audience of senior business development and
investment executives from the leading medical technology and
healthcare investment firms worldwide, for purposes of raising funding
or forming strategic partnerships. Regularly updated event details can
be viewed at www.windhover.com/in3europe08.
Presentations from a carefully selected group of cutting-edge,
early- to late-stage companies will encompass a wide variety of
high-growth device market sectors. Presenters confirmed to date
include Arterial Remodeling Technologies, Biomedix SA, Cardiatis,
Cardio3 Biosciences SA, CardioLa, Ltd., Ceragenix Pharmaceuticals, ES
Vascular Ltd., Gendel Ltd., InitiaRT, Intellwave, LLC, MagForce
Nanotechnologies GmbH, Mini-Lap, Inc., mNemoscience GmbH, Nano Biotix,
NanoPowers SA, Nerites Corporation, Ovalum Ltd., Photo Dynamic
Therapy, Praxim, SA, ProRhythm, Inc., Retina-Implant GmbH, Science &
Technology International, Small Bone Innovations, LLC, Symetis SA,
Vivoxid, and Xylos Corporation, among others being added to the
program regularly.
The In3 Europe format will include focused 10-minute presentations
by a senior executive from each presenting company to our full
audience, each followed immediately by one-on-one meetings with
interested parties in private breakout rooms. The event will also
feature an insightful Keynote Presentation by David Cassak, Managing
Partner at Windhover Information, entitled "State of the Medical
Device Industry," and an informative and interactive Panel Discussion,
"Trends in European Dealmaking and Investing," with esteemed panelists
to include Christophe Douat, Partner, Matignon Investissement &
Gestic; Dr. Olivier Litzka, Partner, Edmond de Rothschild Investment
Partners; Antoine Papiernik, Managing Partner, Sofinnova Partners;
Yuval Binur, Founder & General Partner, Accelerated Technologies
Partners; and Thom Rasche, Venture Partner, Earlybird Ventures. The
program will also feature a presenting company product
exhibition/networking reception, and educational workshops. In3 Europe
co-sponsoring companies include Business Wire, MDMA, Ronald Trahan
Associates, Summit Corporate Services, and The Gray Sheet.
In3 Europe's growing attendee list includes a robust line-up of
buy-side/investors from around the world. A sample of companies
sending their teams include: Abingworth Management Ltd., Accelerated
Technologies, Inc., Accuitive Medical Ventures, Astra Tech AB, Averion
Europe GmbH, Baylor College of Medicine, Banexi Ventures Partners,
Bayer Innovation, GmbH, BayTech Venture Capital, BD Medical
Pharmaceutical Systems, Boston Scientific International, SA,
Ceramconcept LLC, Earlybird Ventures, Edwards Lifesciences
Corporation, Enterprise Ireland, Ethicon, ev3 Europe SAS, Flanders
Investment & Trade Agency, Gilde Healthcare Partners, Johnson &
Johnson Medical Asia Pacific, Johnson & Johnson, Wound Management,
Kimberly-Clark Health Care, Kobayashi Pharmaceuticals of America,
Kyphon, Inc., LMA International NV, Matignon Technologies FCPR,
Medrad, Inc., Medtronic Europe Sarl, Moscow Investment and Export
Promotion Agency, NBGI Ventures, Nippon Sigmax Company, Ltd., Noble
Fund Managers, Novartis Venture Fund, Oakes, Lyman & Company, Ltd., PA
Consulting, Pfizer, Plus Orthopedics AG/Smith & Nephew, Polaris
Venture Partners, Prism Venture Partners, Quintiles Consulting,
Rothschild Gestion-Paris, Rothschild Investment Partners, Ruston Poole
International, Scottish Equity Partners, Smith & Nephew, Sofinnova
Partners, Stryker Corporation, Teijin Pharma, Ltd., Truffle Capital,
Wellington Partners, Zarlink Semiconductor, and Zimmer GmbH, among
many others.
Medtech Insight and its parent company, Windhover Information,
have established a reputation as holding the premier forums worldwide
for discerning senior executives in the medical device, diagnostics,
biotech, and pharmaceutical business development and investment
communities to meet and screen promising early-stage life sciences
companies in need of funding, acquisition and/or strategic
partnership, and to network with key decision makers in the industry.
Over 1350 emerging medical technology company presenters and over 7200
attendees have participated at In3 events over the past 7 years.
Medtech Insight and Windhover Information will also be holding
their "In3 Medical Device Summit" conference in San Francisco, CA,
June 17-19, featuring over 50 medtech company presentations in 3
concurrent specialty tracks, as well as their annual "In3 East"
conference in Boston, MA, October 22-24. For more information on these
upcoming events, please call Medtech Insight or visit the company's
website at www.medtechinsight.com.
About Medtech Insight
Medtech Insight, a division of Windhover Information Inc., is the
leading provider of business information and market intelligence for
the medical technology marketplace. For more on the company's products
and services, please see www.medtechinsight.com.
Medtech Insight, a division of Windhover Information Inc.
Kristy Grimes, 480-985-9512
or 888-202-5939 toll-free in the U.S.
kristy@medtechinsight.com
www.windhover.com/in3europe08
Copyright Business Wire 2008
